ASTRAZENECA GETS CDSCO APPROVAL TO IMPORT REVOLUTIONARY ANTI-CANCER DRUG “LYNPARZA”
AstraZeneca Pharma India has received CDSCO approval to import its anti-cancer drug Lynparza (olaparib) in 100 mg and 150 mg…
ANTI-CANCER DRUG
Read More
July 29, 2026
- TISHHA Consultants LLP Celebrates Two Years of Dedicated Service in Healthcare and Hospital Administration
- HDFC Bank CSR Initiative Strengthens Critical Care in Tamil Nadu
- Haryana Issues Standard Operating Guidelines for Withdrawal of Life Support
- Johnson & Johnson Agrees to $5.5 Billion Settlement in Talc Cancer Lawsuits